Skip to content
10-Q

Quarterly Report

ANGIOGENEX, INC.

0001469709-19-000093

← back to feed
Filed
May 20, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2019 · Mar 31, 2019 −$116.28K
Operating Cash Flow Q1 2019 · Mar 31, 2018 −$112.79K
Stockholders Equity Q1 2019 · Mar 31, 2019 −$1.06M
Stockholders Equity Q1 2019 · Dec 31, 2018 −$1.07M
Stockholders Equity Q1 2019 · Dec 31, 2017 −$654.52K
Current Liabilities Q1 2019 · Mar 31, 2019 $1.15M
Current Liabilities Q1 2019 · Dec 31, 2018 $1.1M
Total Liabilities Q1 2019 · Mar 31, 2019 $1.18M
Total Liabilities Q1 2019 · Dec 31, 2018 $1.12M
Current Assets Q1 2019 · Mar 31, 2019 $119.66K
Current Assets Q1 2019 · Dec 31, 2018 $52.82K
Total Assets Q1 2019 · Mar 31, 2019 $119.66K
Total Assets Q1 2019 · Dec 31, 2018 $52.82K
Sga Expense Q1 2019 · Mar 31, 2019 $482.52K
Sga Expense Q1 2019 · Mar 31, 2018 $188.44K
Rd Expense Q1 2019 · Mar 31, 2019 $94.48K
Rd Expense Q1 2019 · Mar 31, 2018 −$10.37K
Net Income Q1 2019 · Mar 31, 2019 −$579.28K
Net Income Q1 2019 · Mar 31, 2018 −$180.94K
Operating Income Q1 2019 · Mar 31, 2019 −$576.93K
Operating Income Q1 2019 · Mar 31, 2018 −$178.06K
Shares Outstanding Q1 2019 · Mar 27, 2019 30.39M sh